You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Role of microRNA in chronic lymphocytic leukemia onset and progression
|
|---|---|
| Published in |
Journal of Hematology & Oncology, February 2015
|
| DOI | 10.1186/s13045-015-0112-x |
| Pubmed ID | |
| Authors |
Veronica Balatti, Yuri Pekarky, Carlo M Croce |
| Abstract |
B-cell chronic lymphocytic leukemia (CLL) is the most common human leukemia occurring as indolent or aggressive form. CLL clinical features and genetic abnormalities are well documented, but molecular details are still under investigation. MicroRNAs are small non-coding RNAs involved in several cellular processes and expressed in a tissue-specific manner. MicroRNAs regulate gene expression, and their deregulation can alter expression levels of genes involved in development/progression of tumors. In CLL, microRNAs can function as oncogenes or tumor suppressors and can also serve as markers for CLL onset/progression. Here, we discuss the most recent findings about the role of microRNAs in CLL and how this knowledge can be used to identify new biomarkers and treatment approaches. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 33% |
| United Kingdom | 1 | 17% |
| Unknown | 3 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 2 | 2% |
| Portugal | 1 | <1% |
| Uruguay | 1 | <1% |
| South Africa | 1 | <1% |
| Unknown | 96 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 21 | 21% |
| Student > Ph. D. Student | 17 | 17% |
| Student > Bachelor | 15 | 15% |
| Researcher | 9 | 9% |
| Professor > Associate Professor | 6 | 6% |
| Other | 16 | 16% |
| Unknown | 17 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 31 | 31% |
| Agricultural and Biological Sciences | 17 | 17% |
| Medicine and Dentistry | 16 | 16% |
| Chemistry | 4 | 4% |
| Immunology and Microbiology | 3 | 3% |
| Other | 10 | 10% |
| Unknown | 20 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 April 2015.
All research outputs
#12,724,551
of 22,792,160 outputs
Outputs from Journal of Hematology & Oncology
#580
of 1,191 outputs
Outputs of similar age
#112,693
of 254,710 outputs
Outputs of similar age from Journal of Hematology & Oncology
#8
of 19 outputs
Altmetric has tracked 22,792,160 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,191 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.7. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 254,710 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.